The Tumor-Agnostic Oncology Drug Market is experiencing rapid growth as precision medicine reshapes cancer treatment by focusing on genetic mutations rather than tumor origin. Tumor-agnostic oncology drugs target specific molecular or genomic alterations found across multiple cancer types, enabling personalized treatment approaches and improving clinical outcomes. https://www.databridgemarketresearch.com/reports/global-tumor-agnostic-oncology-drug-market